# Safety and Efficacy of PG102P for Uremic Pruritus in HD Patients

> **NCT03576235** · NA · COMPLETED · sponsor: **Seoul National University Boramae Hospital** · enrollment: 80 (actual)

## Conditions studied

- Uremic Pruritus

## Interventions

- **DRUG:** PG102P
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03576235
- **Lead sponsor:** Seoul National University Boramae Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-01
- **Primary completion:** 2019-01-31
- **Final completion:** 2019-03-30
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2019-09-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03576235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03576235, "Safety and Efficacy of PG102P for Uremic Pruritus in HD Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03576235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*